mHealth Screening To Prevent Strokes
The mHealth Screening To Prevent Strokes (mSToPS) trial is a home-based clinical research study that uses wearable sensor technology to identify people with asymptomatic Atrial Fibrillation (AFib), an irregular heartbeat (arrhythmia) that can lead to blood clots, stroke and heart failure. The primary objective of the trial is to determine whether screening select individuals in their homes using wearable medical devices can identify people with asymptomatic AFib more efficiently than routine care.
The study, launched in November 2015, is a novel multisectoral collaboration between Scripps Translational Science Institute (STSI), Aetna’s Innovation Labs and Healthagen Outcomes units, and Janssen Pharmaceuticals, Inc.
Study participants will undergo continuous single-lead electrocardiogram (ECG) monitoring using the ZIO® XT Patch wearable sensor, developed by iRhythm Technologies. Additionally, a subset of participants will be invited to participate in a substudy that monitors heart rate and rhythm characteristics through the Amiigo wristband monitor.